CRD42022382594 Graphical Abstract Similar content being viewed by others Introduction Semaglutide, administered s.c., has shown superior efficacy compared with other glucose-lowering agents, including its oral formulation, in reducing HbA 1c and in facilitating weight loss in individuals with type 2 diabetes [1, 2]
Melbourne Bariatric and Endoscopic Surgeon Dr Jason Winnett says, The treatment of obesity is not like taking paracetamol to treat a cold, or an infection where you take antibiotics and youre done
Wegovy Data as Reported by Novo Nordisk The manufacturers language on the weight loss indication reads thus: Wegovy (semaglutide) injection 2.4 mg is indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged 12 years and older with obesity and adults with overweight in the presence of at least one weight-related comorbidity. At two years, patients taking Wegovy showed a mean weight loss of 15% or 34 pounds, from a mean baseline BMI of 38.5
Otherwise, you should skip the missed dose and stay on your regular schedule
Lancet Psychiatry